Researchers call for more study of medication side effects in pregnant broodmares by Amanda Duckworth IT IS LOGICAL that a happy, healthy broodmare is more likely to have an easier time with her pregnancy...
Read More
From long before sunrise to well past sunset Sept. 25, activities took place on the grounds of Keeneland Race Course that should have a ripple effect on the future of Thoroughbred racing in North America...
Read More
In our previous column we discussed how the Racing Medication & Testing Consortium determines the regulatory thresholds for therapeutic drugs. We looked at this process because the National Horsemen’s...
Read More
Several weeks ago we questioned the effectiveness of a National Horsemen's Benevolent and Protective Association call for medication research to be conducted, and possibly adopted, independently of the...
Read More
How many ways can the racing industry find to undermine its own efforts? Sadly, too many. The most recent surfaced last week when the National Horsemen's Benevolent and Protective Association announced...
Read More
Mirroring the debate about medication use itself, the Thoroughbred racing industry is sharply divided over ongoing efforts to create a national medication monitoring and enforcement program through federal...
Read More
Olympic gold medalist Edwin Moses challenged Thoroughbred racing’s industry leaders to do some serious self-evaluation during the 63rd Annual Round Table Conference conducted by The Jockey Club. Moses...
Read More
Several issues and questions have surfaced following the introduction July 15 of federal legislation that would authorize the United States Anti-Doping Agency to create an independent organization to oversee...
Read More
What to do with Doug O’Neill and his most recent drug positive in New York that resulted in a 45-day suspension for the Southern California-based trainer and a ban from participating in the Breeders’ Cup...
Read More
@font-face { font-family: "Times"; }@font-face { font-family: "Cambria"; }p.MsoNormal, li.MsoNormal, div.MsoNormal { margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: "Times New Roman"; }p.MsoFooter...
Read More
